Method for propagating adenoviral vectors encoding inhibitory gene products
AssigneeGenVec, Inc.
InventorsJason G.D. Gall, Douglas E. Brough, C. Richter King
Life of this patent
Estimating the term…
Loading patent…
AssigneeGenVec, Inc.
InventorsJason G.D. Gall, Douglas E. Brough, C. Richter King
Estimating the term…
The invention provides a method of propagating an adenoviral vector. The method comprises (a) providing a cell comprising a cellular genome comprising a nucleic acid sequence encoding a tetracycline operon repressor protein (tetR), and (b) contacting the cell with an adenoviral vector comprising a heterologous nucleic acid sequence encoding a toxic protein. The heterologous nucleic acid sequence is operably linked to a promoter and one or more tetracycline operon operator sequences (tetO), and expression of the heterologous nucleic acid sequence is inhibited in the presence of tetR, such that the adenoviral vector is propagated. The invention also provides a system comprising the aforementioned cell and adenoviral vector.
A method of propagating a non-subgroup C adenoviral vector, which method comprises:
A system comprising:
Dependencies are inferred from the claim text.